scispace - formally typeset
P

Paolo Montuschi

Researcher at Catholic University of the Sacred Heart

Publications -  158
Citations -  8760

Paolo Montuschi is an academic researcher from Catholic University of the Sacred Heart. The author has contributed to research in topics: Exhaled breath condensate & Asthma. The author has an hindex of 51, co-authored 146 publications receiving 7862 citations. Previous affiliations of Paolo Montuschi include The Catholic University of America & Agostino Gemelli University Polyclinic.

Papers
More filters
Journal ArticleDOI

Isoprostanes: markers and mediators of oxidative stress

TL;DR: Measurement of F2‐isoprostanes has emerged as one of the most reliable approaches to assess oxidative stress status in vivo, providing an important tool to explore the role of oxidative stress in the pathogenesis of human disease.
Journal ArticleDOI

Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort

Dominick E. Shaw, +56 more
TL;DR: U-BIOPRED is characterised by poor symptom control, increased comorbidity and airway inflammation, despite high levels of treatment, and is well suited to identify asthma phenotypes using the array of "omic" datasets that are at the core of this systems medicine approach.
Journal ArticleDOI

A European respiratory society technical standard : exhaled biomarkers in lung disease

TL;DR: Application of breath biomarker measurement in a standardised manner will provide comparable results, thereby facilitating the potential use of these biomarkers in clinical practice, and highlighting future research priorities in the field.
Journal ArticleDOI

Acute Effects of Air Pollution on Pulmonary Function, Airway Inflammation, and Oxidative Stress in Asthmatic Children

TL;DR: Air pollution may increase airway oxidative Stress and decrease small airway function of asthmatic children and inhaled corticosteroids may reduce oxidative stress and improveAirway function.
Journal ArticleDOI

Exhaled leukotrienes and prostaglandins in COPD

TL;DR: There is a selective increase in exhaled LTB4 and PGE2 in patients with COPD which may be relatively resistant to inhaled corticosteroid therapy.